Longitude Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 18

Professionals

  • Investments
  • 152

  • Portfolio
  • 35

  • Exits
  • 96

Exits

Longitude Capital General Information

Company Description

Founded in 1997, Longitude Capital is a venture capital firm based in Menlo Park, California. The firm prefers to make investments in start-ups to growth companies in pharmaceuticals, biotechnology, healthcare devices, and life sciences sectors.

Business Details

Year Founded
1997
Investor Status
Actively Seeking New Investments
Trade Association
New England Venture Capital Association (NEVCA)
National Venture Capital Association (NVCA)
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Corporate Office
  • 2740 Sand Hill Road
  • 2nd Floor
  • Menlo Park, CA 94025
  • United States
+1 (650) 000-0000

Longitude Capital Investments (152)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
BioAge 01-Feb-2024 Later Stage VC 00000 Drug Discovery Clinical Trials - Phase 2
Cohere Health 26-Jan-2024 00000 00000 0000 Outcome Management (Healthcare) Generating Revenue
Nalu 21-Dec-2023 00000 00000 0000 Therapeutic Devices Generating Revenue 000000 000000
Lassen Therapeutics 19-Dec-2023 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 00000 000 00
OrsoBio 07-Nov-2023 00000 00000 000.00 Drug Discovery Generating Revenue 0000 00000000
Cortica (Clinics/Outpatient Services) 29-Sep-2023 00000 00000 00000 Clinics/Outpatient Services Generating Revenue 0000000 0000
CG Oncology 28-Jul-2023 00000 00000 00000 Drug Discovery Clinical Trials - Phase 3 00000 000 00
Quanta Therapeutics 10-May-2023 00000 00000 000.00 Drug Delivery Clinical Trials - Phase 1
NOCD 18-Jan-2023 Later Stage VC 0000 Practice Management (Healthcare) Generating Revenue
Opna Bio 21-Nov-2022 Early Stage VC 0000 Drug Discovery Pre-Clinical Trials 0000000 0000000
You’re viewing 10 of 152 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Longitude Capital Exits (96)

Company Name Exit Date Exit Type Exit Size
CG Oncology 25-Jan-2024 IPO 00000
LimFlow 15-Nov-2023 000000000000000000 00000
Lexeo Therapeutics 03-Nov-2023 000 00000
Tricida 11-Jan-2023 0000000000: 000000
Eargo 25-Nov-2022 0000000000 000.00
Neurana Pharmaceuticals 18-Oct-2022 000 00 00000000
Dascena 03-Aug-2022 000000000000000000
Sierra Oncology 01-Jul-2022 000000000000000000 00.00
Velicept Therapeutics 01-Jul-2022 Out of Business
89bio 30-Jun-2022 Public Investment 2nd Offering 000.00
You’re viewing 10 of 96 exits. Get the full list »

Longitude Capital Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Longitude Capital‘s full profile, request access.

Request a free trial

Longitude Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Longitude Capital Management, Team & Partners (52)

Name Title Deals Funds Boards Office
Carolyn Helms Chief Financial Officer & Managing Director Menlo Park, CA
Juliet Bakker Co-Founder & Managing Director 00 0 0 Greenwich, CT
Marc Galletti Co-Founder & Managing Director 0 0 0 Menlo Park, CA
Brian Liu MD Managing Director 0 0 Menlo Park, CA
Matthew Young Managing Director 0 Menlo Park, CA
You’re viewing 5 of 52 team members. Get the full list »

Longitude Capital Co-Investors (178)

Name With Exits Lead Partner Series Industry
RA Capital Management 8 0 Series chart Industry bar
Sofinnova Investments 0 0 0 Series chart Industry bar
Frazier Healthcare Partners 0 0 0 Series chart Industry bar
Omega Funds 0 0 0 Series chart Industry bar
T. Rowe Price 0 0 0 Series chart Industry bar
You’re viewing 5 of 178 co-investors. Get the full list »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »